Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Frazier has acquired Altruix, a behavioral health pharmacy business in New York, for an undisclosed amount. Altruix provides pharmacy services for patients with severe mental illness, substance use disorders, and intellectual and developmental disabilities, supporting medication access and continuity of care. The Frazier acquisitions expand healthcare M&A capabilities in NY acquisitions by adding a specialized pharmacy acquisition focused on behavioral health needs. The add on acquisition is structured as an add on acquisition within private equity acquisition activity, with Frazier as a private equity buyer pursuing growth through add on acquisition strategy; terms and expected close timing were not disclosed.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026